Population pharmacokinetics of single-dose amikacin in critically ill patients with suspected ventilator-associated pneumonia

Predictors of insufficient amikacin peak concentration in critically ill patients receiving a 25 mg/kg total body weight regimen

(2014) Etienne de Montmollin et al.   INTENSIVE CARE MEDICINE

Population pharmacokinetics and dosing simulations of amoxicillin/clavulanic acid in critically ill patients

(2013) M. Carlier et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

The Relationship between Drug Clearance and Body Size

(2012) Sarah C. McLeay et al.   CLINICAL PHARMACOKINETICS

Ventilator-associated pneumonia and its prevention

(2012) Lila Bouadma et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Outcomes in severe sepsis and patients with septic shock: Pathogen species and infection sites are not associated with mortality*

(2011) Jean-Ralph Zahar et al.   CRITICAL CARE MEDICINE

Higher than recommended amikacin loading doses achieve pharmacokinetic targets without associated toxicity

(2011) Ricardo Gálvez et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Population Pharmacokinetic Modeling and Optimal Sampling Strategy for Bayesian Estimation of Amikacin Exposure in Critically Ill Septic Patients

(2010) Isabelle K Delattre et al.   THERAPEUTIC DRUG MONITORING

Pharmacokinetic issues for antibiotics in the critically ill patient

(2009) Jason A. Roberts et al.   CRITICAL CARE MEDICINE

Evaluation of population pharmacokinetic models for amikacin dosage individualization in critically ill patients

(2009) María del Mar Fernández de Gatta et al.   JOURNAL OF PHARMACY AND PHARMACOLOGY

Antimicrobial breakpoints for Gram-negative aerobic bacteria based on pharmacokinetic–pharmacodynamic models with Monte Carlo simulation

(2008) Christopher R. Frei et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY